Needle-Delivered cancer treatment shows promise in early trials
NCT ID NCT07339176
Summary
This study is testing an experimental medicine called N17350, which is injected directly into tumors of adults with advanced solid cancers that have spread or stopped responding to standard treatments. The main goals are to find the safest and most effective dose, check for side effects, and see if the injections cause tumors to shrink or stop growing. All participants will receive N17350 injections into their tumors every two weeks for 8-12 weeks while being closely monitored.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Westmead Hospital
Westmead, New South Wales, 2145, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.